Kasuki L - Search Results

1

Splicing Machinery is Dysregulated in Pituitary Neuroendocrine Tumors and is Associated with Aggressiveness Features.

Vázquez-Borrego MC, Fuentes-Fayos AC, Venegas-Moreno E, Rivero-Cortés E, Dios E, Moreno-Moreno P, Madrazo-Atutxa A, Remón P, Solivera J, Wildemberg LE, Kasuki L, López-Fernández JM, Gadelha MR, Gálvez-Moreno MA, Soto-Moreno A, Gahete MD, Castaño JP, Luque RM. Vázquez-Borrego MC, et al. Among authors: kasuki l. Cancers (Basel). 2019 Sep 26;11(10):1439. doi: 10.3390/cancers11101439. Cancers (Basel). 2019. PMID: 31561558 Free PMC article.

2

Growth of an aggressive tumor during pregnancy in an acromegalic patient.

Kasuki L, Neto LV, Takiya CM, Gadelha MR. Kasuki L, et al. Endocr J. 2012;59(4):313-9. doi: 10.1507/endocrj.ej11-0306. Epub 2012 Jan 12. Endocr J. 2012. PMID: 22240890 Free article.

3

AIP expression in sporadic somatotropinomas is a predictor of the response to octreotide LAR therapy independent of SSTR2 expression.

Kasuki L, Vieira Neto L, Wildemberg LE, Colli LM, de Castro M, Takiya CM, Gadelha MR. Kasuki L, et al. Endocr Relat Cancer. 2012 May 24;19(3):L25-9. doi: 10.1530/ERC-12-0020. Print 2012 Jun. Endocr Relat Cancer. 2012. PMID: 22420004 No abstract available.

4

Acromegalic patients lost to follow-up: a pilot study.

Kasuki L, Marques NV, Nuez MJ, Leal VL, Chinen RN, Gadelha MR. Kasuki L, et al. Pituitary. 2013 Jun;16(2):245-50. doi: 10.1007/s11102-012-0412-x. Pituitary. 2013. PMID: 22821645

5

Novel pathway for somatostatin analogs in patients with acromegaly.

Gadelha MR, Kasuki L, Korbonits M. Gadelha MR, et al. Among authors: kasuki l. Trends Endocrinol Metab. 2013 May;24(5):238-46. doi: 10.1016/j.tem.2012.11.007. Epub 2012 Dec 25. Trends Endocrinol Metab. 2013. PMID: 23270713 Review.

6

Resistance to octreotide LAR in acromegalic patients with high SSTR2 expression: analysis of AIP expression.

Kasuki L, Colli LM, Elias PC, Castro Md, Gadelha MR. Kasuki L, et al. Arq Bras Endocrinol Metabol. 2012 Nov;56(8):501-6. doi: 10.1590/s0004-27302012000800007. Arq Bras Endocrinol Metabol. 2012. PMID: 23295289

7

Ki-67 is a predictor of acromegaly control with octreotide LAR independent of SSTR2 status and relates to cytokeratin pattern.

Kasuki L, Wildemberg LE, Neto LV, Marcondes J, Takiya CM, Gadelha MR. Kasuki L, et al. Eur J Endocrinol. 2013 Jul 15;169(2):217-23. doi: 10.1530/EJE-13-0349. Print 2013 Aug. Eur J Endocrinol. 2013. PMID: 23749849

8

ZAC1 and SSTR2 are downregulated in non-functioning pituitary adenomas but not in somatotropinomas.

Vieria Neto L, Wildemberg LE, Colli LM, Kasuki L, Marques NV, Moraes AB, Gasparetto EL, Takiya CM, Castro M, Gadelha MR. Vieria Neto L, et al. Among authors: kasuki l. PLoS One. 2013 Oct 2;8(10):e77406. doi: 10.1371/journal.pone.0077406. eCollection 2013. PLoS One. 2013. PMID: 24098585 Free PMC article.

9

Acromegaly and pregnancy: a prospective study.

Dias M, Boguszewski C, Gadelha M, Kasuki L, Musolino N, Vieira JG, Abucham J. Dias M, et al. Among authors: kasuki l. Eur J Endocrinol. 2013 Dec 21;170(2):301-10. doi: 10.1530/EJE-13-0460. Print 2014 Feb. Eur J Endocrinol. 2013. PMID: 24247731

10

MicroRNAs: Suggested role in pituitary adenoma pathogenesis.

Gadelha MR, Kasuki L, Dénes J, Trivellin G, Korbonits M. Gadelha MR, et al. Among authors: kasuki l. J Endocrinol Invest. 2013 Nov;36(10):889-95. doi: 10.1007/BF03346759. J Endocrinol Invest. 2013. PMID: 24317305 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

83 results

Search Page